On December 13, 2023, vTv Therapeutics Inc Received A Letter From The Nasdaq Stock Market Notifying The Company That It Is Not In Compliance With The Requirement Of Nasdaq Listing Rules
Portfolio Pulse from Benzinga Newsdesk
vTv Therapeutics Inc. received a non-compliance notice from Nasdaq due to its securities being below the required market value of $35 million for 30 consecutive days. The company has until June 10, 2024, to regain compliance or face delisting. vTv Therapeutics is exploring options to meet the requirements but there's no assurance of compliance.

December 19, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
vTv Therapeutics Inc. received a Nasdaq non-compliance notice and risks delisting if it doesn't meet the MVLS requirement by June 10, 2024.
The non-compliance notice is a significant negative regulatory event that directly affects vTv Therapeutics Inc. It puts pressure on the company to act to regain compliance, which may include raising capital, restructuring, or other measures that could dilute current shareholders or otherwise impact the stock price negatively. The risk of delisting can also lead to a loss of investor confidence and may result in a decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100